On that basis we selected MSR3‐mel, a melanoma‐derived cell line reported to display an epigenetic silencing of HLA‐I genes by hypermethylation, also preventing the presence of HLA‐I leader sequences binding to HLA‐E [38]. The gene discussed is HLA-E; the disease is melanoma.